Concinnity Genetics is a startup based in the United Kingdom.
Develops an AI-driven synthetic biology platform to design novel control mechanisms that improve the safety of gene and cell therapies. Partners with biopharma organisations to optimise and expand the applications of gene therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.